The Effects of Preemptive Multimodal Analgesic on Endodontic Pain Following Root Canal Therapy.

February 9, 2026 updated by: Prof. Dr. Md. Abu Saeed Ibn Harun, Chattogram International Dental College

The Effects of Preemptive Multimodal Analgesic on Endodontic Pain.

A clinical trial comparing preemptive multimodal analgesics with placebo in the management of immediate and chronic post-endodontic pain. The study utilizes statistical methods such as chi-squared, T-tests, and regression analysis, accounting for multiple outcomes with the Bonferroni adjustment. Duloxetine hydrochloride and pregabalin, both available in Bangladesh, are evaluated as experimental drugs, while placebos are used to assess psychological effects on pain. All participants receive standard interventional treatments, with acetaminophen provided as needed, and ethical considerations are addressed according to international guidelines.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

280

Phase

  • Early Phase 1

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Chattogram
      • Chittagong, Chattogram, Bangladesh, 4212
        • Recruiting
        • Professor. Dr. Md. Abu Saeed Ibn Harun
        • Contact:
        • Contact:
        • Sub-Investigator:
          • Suparna Das, BDs

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  1. Patient's aged 18 years more.
  2. ASA physical status I-II.
  3. Patient with the complain of pain originated from teeth and surrounding structure.
  4. Preoperative pain severity is moderate to severe.
  5. Patient can be able to make communication about their pain.
  6. Patients give consent to attain this research.
  7. Patients have others concomitant chronic pain.
  8. Patients who will have non-surgical endodontic treatment.
  9. Patients who will have non-surgical endodontic retreatment.
  10. Patients who will have surgical endodontic treatment.

Exclusion Criteria:

  1. Patient would not like to attain in research.
  2. Patients have any medical condition those are contra indication for study drug.
  3. ASA physical status III, IV, V.
  4. Patient already under treated any anti convulsent drug.
  5. Patient participant in other clinical trials.
  6. Lack of motivation or poor adharence to study protocols.
  7. Patient with Pregnancy
  8. Severe organ dysfunction
  9. Patient have Hepatitis B, and other cross infection disease like (HIV)
  10. Uncontrolled comorbidities that patient do not fit for endodontic treatment.
  11. Severe cognitive impaired patients.
  12. History of certain cancers or severe hematological issues.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Multimodal Analgesia

Preemptive Multi modal analgesic drug: Experimental group will be divided into 2 subgroups according to use of drug.

A. Pregabalin-acetaminophen. B. Duloxetine-Acetaminophen Pregabalin-acetaminophen: Before a half-hour endodontic treatment, patients in this group will receive a single dosage of 50 mg pregabalin and 500 mg acetaminophen. If necessary, acetaminophen dosages of 500 mg will be administered three times a day.

Duloxetine-Acetaminophen: Prior to a half-hour endodontic treatment, patients in this group will receive a single dosage of 500 mg of acetaminophen and 30 mg of Duloxetine. If necessary, acetaminophen dosages of 500 mg will be administered three times a day.

Preemptive Multi modal analgesic drug: Experimental group will be divided into 2 subgroups according to use of drug.

A. Pregabalin-acetaminophen. B. Duloxetine-Acetaminophen Pregabalin-acetaminophen: Before a half-hour endodontic treatment, patients in this group will receive a single dosage of 50 mg pregabalin and 500 mg acetaminophen. If necessary, acetaminophen dosages of 500 mg will be administered three times a day.

Duloxetine-Acetaminophen: Prior to a half-hour endodontic treatment, patients in this group will receive a single dosage of 500 mg of acetaminophen and 30 mg of Duloxetine. If necessary, acetaminophen dosages of 500 mg will be administered three times a day.
Placebo Comparator: Control
Placebo: Patient in this group will receive placebo drug before half an hour of operating procedure. If necessary, acetaminophen dosages of 500 mg will be administered three times a day and noted

Preemptive Multi modal analgesic drug: Experimental group will be divided into 2 subgroups according to use of drug.

A. Pregabalin-acetaminophen. B. Duloxetine-Acetaminophen Pregabalin-acetaminophen: Before a half-hour endodontic treatment, patients in this group will receive a single dosage of 50 mg pregabalin and 500 mg acetaminophen. If necessary, acetaminophen dosages of 500 mg will be administered three times a day.

Duloxetine-Acetaminophen: Prior to a half-hour endodontic treatment, patients in this group will receive a single dosage of 500 mg of acetaminophen and 30 mg of Duloxetine. If necessary, acetaminophen dosages of 500 mg will be administered three times a day.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Effects of Preemptive multimodal analgesia on post endodontic pain
Time Frame: 6, 12, 24, 48, 72 hours
Primary Pain during endodontic treatment and the effectiveness of intervention will be evaluated at 6, 12, 24, 48, 72, and hourly intervals after the endodontic procedure. Treatment-related anaesthetic efficacy will be assessed using the VAS (Visual Analogue Scale; numerical value 0-10). During endodontic treatment, the level of pain will decide how effective the anesthetic is. The patient will be asked to rate the analgesic effects on a VAS (Visual Analogue Scale) scale by providing a numerical number 0-10. '0" are indicated no pain, 1-3= mild pain, 4-6= moderate pain, 7-10= sever pain.
6, 12, 24, 48, 72 hours

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Mechanical Detection Threshold
Time Frame: baseline, 72 hours
Mechanical Detection Threshold: A standardized set of modified von Frey hairs (Opti-hair2-Set, Marstock Nervtest, Germany) that exert stresses upon bending between 0.25 and 512 mN graded by a factor of 2 (1-2 s contact time) were used to determine the mechanical detection threshold (MDT). With a rounded tip and 0.5 mm in diameter, the von Frey hairs' contact area with the skin was consistent in size and shape to prevent sharp edges that could aid in nociceptor activation. Five threshold determinations with a sequence of increasing and decreasing stimulus intensities were made using the "method of limits." The geometric mean of these five series served as the final threshold.
baseline, 72 hours
Mechanical Pain Threshold
Time Frame: baseline, 72 hours
Mechanical Pain Threshold: A set of seven pin-prick mechanical stimulators with preset stimulus intensities (flat contact area of 0.2 mm diameter) that applied forces of 8, 16, 32, 64, 128, 256, and 512 mN were used to test the mechanical pain threshold (MPT). These stimuli were custom-made and weighted. Until the first perception of sharpness was attained, the stimulators were applied in ascending order at a pace of two seconds on, two seconds off. The geometric mean of five sequences of rising and descending stimuli served as the final threshold. The purpose of this test was to identify pinprick hypoalgesia. Before initiation of endodontic treatment, the patient has to take drug that's are supplied in enveloped.
baseline, 72 hours
Mechanical Pain Sensitivity
Time Frame: baseline, 72 hours
Mechanical Pain Sensitivity will test using the same weighted pinprick stimuli as for mechanical pain threshold. To obtain a stimulus- response- function, these seven pinprick stimuli will apply in a balanced order, five times each, and patient will ask to give a pain rating for each stimulus on a 0-10 VAS scale ( '0' indicate no pain; 10 indicate most intense pain imaginable.
baseline, 72 hours

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 6, 2026

Primary Completion (Estimated)

March 30, 2027

Study Completion (Estimated)

April 30, 2027

Study Registration Dates

First Submitted

January 26, 2026

First Submitted That Met QC Criteria

February 9, 2026

First Posted (Actual)

February 10, 2026

Study Record Updates

Last Update Posted (Actual)

February 11, 2026

Last Update Submitted That Met QC Criteria

February 9, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • ERC-BBS/2025/0015-44/2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post Endodontic Pain

Clinical Trials on Pregabalin- Acetaminophen

Subscribe